Metformin Recalled Due to Potential Cancer-Causing Chemical
Recall is for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer
Five-Day Course of Remdesivir Beneficial in Severe COVID-19
No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients
Remdesivir Use Growing Globally in COVID-19 Patients
Yet, most physicians believe it is only moderately effective, better used earlier than official guidelines recommend
AAOS: Opioid Prescribing Down for Minor Ortho Injuries in Youth
However, 54.3 percent of patients received at least one dose of opioid during ED or clinic visit
Improving Glycemic Control May Also Aid COVID-19 Outcomes
Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19
Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure
Lower risk for cardiovascular death or hospital admission seen in HF with reduced ejection fraction
9.5 Percent Uninsured in U.S. From January Through June 2019
Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
